Kendal Ryter

Dr. Kendal Ryter

Chemistry and Biochemistry, University of Montana, Missoula, Montana, USA
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2018 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
ASAlyson J. Smith
Alyson J. Smith
BGBridget Graves
Bridget Graves
RCRobert Child
Robert Child
PRPeter J. Rice
Peter J. Rice
ZMZuchao Ma
Zuchao Ma
DWDavid L. Williams
David L. Williams
Ligation of Dectin-1 by fungal glucans elicits a Th17 response that is necessary for clearing many fungal pathogens. Laminarin is a (1→3, 1→6)-β-glucan that is widely reported to be a Dectin-1 antagonist, however, there are reports that laminarin is also a Dectin-1 agonist. To address this controversy, we assessed the physical properties, structure, purity, Dectin-1 binding, and biological activity of five different laminarin preparations from three different commercial sources. The proton nuclear magnetic resonance analysis indicated that all of the preparations contained laminarin although their molecular mass varied considerably (4400–34,400 Da). Two of the laminarins contained substantial quantities of very low m.w. compounds, some of which were not laminarin. These low m.w. moieties could be significantly reduced by extensive dialysis. All of the laminarin preparations were bound by recombinant human Dectin-1 and mouse Dectin-1, but the affinity varied considerably, and binding affinity did not correlate with Dectin-1 agonism, antagonism, or potency. In both human and mouse cells, two laminarins were Dectin-1 antagonists and two were Dectin-1 agonists. The remaining laminarin was a Dectin-1 antagonist, but when the low m.w. moieties were removed, it became an agonist. We were able to identify a laminarin that is a Dectin-1 agonist and a laminarin that is Dectin-1 antagonist, both of which are relatively pure preparations. These laminarins may be useful in elucidating the structure and activity relationships of glucan/Dectin-1 interactions. Our data demonstrate that laminarin can be either a Dectin-1 antagonist or agonist, depending on the physicochemical properties, purity, and structure of the laminarin preparation employed.


6 December 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Kendal RyterKendal Ryter
Kendal Ryter
GEGeorge Ettenger
George Ettenger
OROMER RASHEED
OMER RASHEED
CBCassandra Buhl
Cassandra Buhl
RCRobert Child
Robert Child
JEJay T. Evans
Jay T. Evans

1 September 2007 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
BNBryan H. Norman
Bryan H. Norman
TRTimothy I. Richardson
Timothy I. Richardson
JDJeffrey A. Dodge
Jeffrey A. Dodge
LPLance A. Pfeifer
Lance A. Pfeifer
GDGregory L. Durst
Gregory L. Durst
Kendal RyterKendal Ryter
Kendal Ryter

28 February 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
ASAlyson J. Smith
Alyson J. Smith
SMShannon M. Miller
Shannon M. Miller
CBCassandra Buhl
Cassandra Buhl
RCRobert Child
Robert Child
MWMargaret Whitacre
Margaret Whitacre
JEJay T. Evans
Jay T. Evans
Despite the ever present need for an effective Mycobacterium tuberculosis (Mtb) vaccine, efforts for development have been largely unsuccessful. Correlates of immune protection against Mtb are not wholly defined, but Th1 and likely Th17 adaptive immune responses have been demonstrated to be necessary for vaccine-mediated protection. Unfortunately, no approved adjuvants are able to drive a Th17 response, though recent clinical trials with CAF01 have demonstrated proof of concept. Herein we present the discovery and characterization of a new class of potential Th17-inducing vaccine adjuvants, alpha-branched trehalose diester molecules (αTDE). Based off the Mtb immunostimulatory component trehalose dimycolate (TDM), we synthesized and evaluated the immunostimulatory capacity of a library of structural derivatives. We evaluated the structure activity relationship of the compounds in relation to chain length and engagement of the Mincle receptor, production of innate cytokines from human and murine cells, and a pro-Th17 cytokine profile from primary human peripheral blood mononuclear cells. Murine cells displayed more structural tolerance, engaging and responding to a wide array of compound chain lengths. Interestingly, human cells displayed a unique specificity for ester chains between 5 and 14 carbons for maximal immune stimulating activity. Evaluation of two distinct αTDEs, B16 and B42, in concert with a recombinant Mtb antigen demonstrated their ability to augment a Th17 immune response against a Mtb antigen in vivo. Collectively this data describes the species-specific structural requirements for maximal human activity of alpha-branched trehalose diester compounds and demonstrates their capacity to serve as potent Th17-inducing adjuvants.

4 January 2003 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
PGPeter R. Guzzo
Peter R. Guzzo
RBRonald N. Buckle
Ronald N. Buckle
MCMing Chou
Ming Chou
SDSean R. Dinn
Sean R. Dinn
MFMichael E. Flaugh
Michael E. Flaugh
YXYao-Chang Xu
Yao-Chang Xu